Danaher Corporation

DHR Healthcare Diagnostics & Research

Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.

228.97 2.53 −1.09%
Market cap
$162.7B
P/E
40.5×
Fwd P/E
29.2×
Dividend yield
0.66%
F-score
6/9
Altman Z
4.52
Beneish M
−2.57
Dividend safety
69/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
18.88 22.89 24.19 33.19 39.62 33.26 23.75 36.40 43.07 45.15
Piotroski F-Score
7 4 8 4 6 6 7 4 7 6
P/S ratio
2.86 3.67 3.76 5.43 6.24 8.40 6.33 7.24 7.03 6.64
Altman Z-Score
2.49 2.95 3.32 3.24 3.37 4.44 4.36 4.54 4.95 4.52
Altman Z″-Score (non-manufacturers)
2.96 3.62 3.96 4.81 3.24 3.33 4.23 4.25 4.37 4.46
P/FCF ratio
16.41 19.40 18.60 29.22 25.66 29.23 22.75 29.85 31.61 30.82
Beneish M-Score
(2.57) (2.45) (2.74) (2.80) (2.22) (2.50) (2.68) (2.63) (2.73) (2.57)
P/Operating CF
74.38 68.31 51.75 87.52 62.62 89.34 66.35 106.81 83.11 77.07
Dividend Safety Score
— — — — — — — — — 69
P/B ratio
2.09 2.16 2.27 3.39 3.81 4.97 3.48 3.23 3.39 3.11
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
3.38 4.30 4.28 5.52 6.92 9.19 6.82 7.69 7.59 7.20
EV/EBITDA
14.75 18.08 17.23 22.18 23.86 26.83 18.79 24.91 25.03 24.79
EV/Operating CF
16.18 19.18 18.14 25.02 24.84 27.28 21.33 25.65 27.10 27.58
EV/FCF
19.37 22.70 21.18 29.71 28.46 31.98 24.52 31.72 34.14 33.43
Quick Ratio
0.60 0.87 0.79 4.68 1.36 0.89 1.20 1.18 0.83 1.25
Current Ratio
0.97 1.43 1.47 5.19 1.86 1.43 1.89 1.68 1.40 1.87
Net Debt/EBITDA
2.25 2.63 2.10 0.36 2.35 2.30 1.35 1.47 1.85 1.93
Debt/Assets
21.36% 22.14% 20.26% 34.66% 27.83% 26.65% 22.63% 19.77% 19.99% 22.06%
Debt/Equity
0.42 0.39 0.34 0.71 0.53 0.49 0.38 0.31 0.31 0.35
Asset Turnover
0.36 0.34 0.36 0.33 0.32 0.31 0.32 0.28 0.29 0.31
Operating CF/Net income
1.38 1.40 1.52 1.34 1.77 1.33 1.20 1.51 1.72 1.78
Capex/Depreciation
(0.51) (0.48) (0.49) (0.52) (0.35) (0.58) (0.52) (0.63) (0.58) (0.46)
Interest Coverage
14.83 18.36 22.30 30.27 15.39 27.61 36.94 18.19 17.49 17.70
ROE
10.90% 10.08% 9.71% 10.33% 10.77% 15.99% 15.73% 9.31% 7.57% 7.08%
ROA
5.46% 5.42% 5.61% 5.35% 5.08% 7.87% 8.48% 5.62% 4.81% 4.49%
ROIC
5.38% 4.46% 5.14% 6.41% 4.81% 6.15% 7.45% 5.05% 4.83% 4.42%
Return on Tangible Assets
119.05% 55.23% 58.89% 12.80% 36.33% 85.90% 63.40% 46.43% 50.71% 31.48%
Average Days of Receivables
68.88 82.83 64.86 65.03 66.25 68.15 56.20 59.92 54.07 58.13
Research and Development Expense of Revenue
5.78% 6.16% 6.21% 6.29% 6.05% 6.04% 5.74% 6.29% 6.63% 6.50%
Selling, General and Administrative Expense of Revenue
33.31% 32.49% 31.62% 31.20% 30.95% 27.49% 26.74% 30.68% 32.50% 33.52%
Intangible Assets out of Total Assets
0.79 0.79 0.69 0.52 0.74 0.77 0.68 0.74 0.76 0.73
Share Based Compensation of Revenue
0.77% 0.82% 0.81% 0.89% 0.84% 0.74% 1.11% 1.28% 1.21% 1.21%
Graham Net Nets
(0.32) (0.24) (0.20) (0.06) (0.16) (0.13) (0.11) (0.10) (0.11) (0.11)
Graham Number
52.72 55.25 58.54 60.83 76.03 107.58 121.28 102.66 90.16 91.70
Earnings Yield
5.30% 4.37% 4.13% 3.01% 2.52% 3.01% 4.21% 2.75% 2.32% 2.21%
Free Cash Flow Yield
6.09% 5.16% 5.38% 3.42% 3.90% 3.42% 4.40% 3.35% 3.16% 3.24%
Revenue per Share
24.42 22.30 24.33 25.05 31.55 34.71 36.74 32.44 32.66 34.47
Operating CF per Share
5.10 5.00 5.74 5.53 8.79 11.70 11.75 9.73 9.15 9.00
Capex per Share
(0.84) (0.77) (0.82) (0.87) (1.12) (1.72) (1.53) (1.86) (1.89) (1.58)
Free Cash Flow per Share
4.26 4.22 4.92 4.66 7.67 9.98 10.22 7.87 7.26 7.43
Cash per Share
1.39 0.91 1.12 27.85 8.55 3.62 8.27 7.96 2.84 6.48
Shareholders Equity per Share
33.39 37.90 40.29 42.35 56.33 63.22 69.08 72.63 67.78 73.72
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
33.39 37.90 40.29 42.35 56.33 63.22 69.08 72.63 67.78 73.72
Free Cash Flow
2,942.00 2,939.60 3,444.00 3,329.00 5,419.00 7,131.00 7,410.00 5,793.00 5,309.00 5,293.00
Working Capital
(208.90) 2,057.70 2,252.30 20,664.00 6,400.00 3,508.00 7,494.00 5,663.00 2,699.00 5,949.00
Capital Expenditures
(579.80) (538.20) (578.00) (623.00) (789.00) (1,227.00) (1,109.00) (1,371.00) (1,379.00) (1,123.00)
Net Current Asset Value
(15,553.40) (13,430.80) (12,512.00) (6,204.00) (22,582.00) (26,359.00) (18,377.00) (17,061.00) (18,495.00) (18,167.00)
EV/EBIT
20.83 25.94 23.88 30.25 36.45 35.76 24.11 35.33 37.27 37.73
Capex to Sales
0.03 0.03 0.03 0.03 0.04 0.05 0.04 0.06 0.06 0.05
Price to Operating Income
17.65 22.17 20.97 29.76 32.87 32.69 22.37 33.24 34.51 34.79
Other line items
Depreciation/Fixed assets
0.48 0.46 0.52 0.52 0.68 0.56 0.57 0.48 0.48 0.44
Cash ROIC
8.73% 7.88% 8.90% 4.64% 8.09% 10.20% 9.86% 7.62% 7.91% 7.00%
Accounts Receivable Turnover
5.47 4.63 5.20 5.76 6.16 5.72 6.10 5.95 6.40 6.60
Accounts Payable Turnover
5.25 4.64 5.02 5.27 5.50 4.14 4.73 5.44 5.50 5.59
Inventory Turnover
4.60 3.91 4.35 4.86 5.00 3.78 3.78 3.68 3.93 4.17
Average Days of Payables
71.81 79.33 72.35 69.76 76.24 98.05 64.80 65.40 66.17 67.00
Days of Inventory on Hand
82.66 96.71 78.93 74.96 85.29 105.61 96.53 96.06 87.96 90.44
Average Receivables
3,085.60 3,353.95 3,275.80 3,110.40 3,618.00 4,338.00 4,366.50 4,012.00 3,729.50 3,725.00
Average Payables
1,438.45 1,497.45 1,502.65 1,505.20 1,782.00 2,309.00 2,212.50 1,811.00 1,759.50 1,798.50
Average Inventory
1,641.25 1,775.10 1,736.10 1,629.70 1,960.00 2,529.50 2,766.00 2,679.50 2,462.00 2,409.50
Average Assets
46,758.75 45,971.95 47,240.55 54,957.25 69,121.50 79,672.50 83,767.00 84,419.00 81,015.00 80,503.00
Average Common Equity
23,420.40 24,722.30 27,297.25 28,454.35 32,595.50 39,209.00 45,165.50 50,956.00 51,520.00 51,045.50

Fold the line items

Columns are period end dates